Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1

Conditions

Breast Neoplasms 11Neoplasms 5Stomach Neoplasms 3Pain, Postoperative 2Pain 2Motor Activity 2Lung Neoplasms 2Head and Neck Neoplasms 2Fatigue 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Sarcoma 1Psychological Well-Being 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Lymphoma 1Lymphedema 1Lymphatic Metastasis 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Leukemia, Myeloid, Acute 1Leukemia 1Incisional Hernia 1Hernia, Abdominal 1Heart Failure 1Esophageal Neoplasms 1Endometrial Neoplasms 1Diarrhea 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Docetaxel 21Radiosurgery 19Radiotherapy 17Androgen Antagonists 14Leuprolide 11Goserelin 11bicalutamide 9enzalutamide 8Surveys and Questionnaires 8Prednisone 8Brachytherapy 8Blood Specimen Collection 8Abiraterone Acetate 8acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7Radiotherapy, Intensity-Modulated 7Multiparametric Magnetic Resonance Imaging 7Gonadotropin-Releasing Hormone 7Triptorelin Pamoate 6pembrolizumab 4cabazitaxel 4abiraterone 4Standard of Care 4Positron Emission Tomography Computed Tomography 4Metformin 4Heavy Ion Radiotherapy 4Exercise 4Estramustine 4luprolide acetate gel depot 3darolutamide 3Watchful Waiting 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms × Control Groups × Clear all
NCT05319145 2022-04-13

PROFIT

Hospital Universitari Vall d'Hebron Research Institute

Phase NA Unknown
268 enrolled
GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡